Eight SEOM Grants awarded to professionals from the Clínic Barcelona Comprehensive Cancer Centre
Professionals from the Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), have been awarded eight gran...
News from Institute of Cancer and Blood Diseases
Hospital Clínic and Vila Casas Foundation promote new artistic interventions at the Cancer and Blood Diseases Institute
Hospital Clínic Barcelona and the Vila Casas Foundation have promoted two new artistic interventions at the Cancer and Blood Diseases Institute (IC...
Researchers identify the mechanisms that drive tumor expansion in Waldenström macroglobulinemia
A study led by Hospital Clínic-IDIBAPS sheds light on how this rare type of lymphoma evolves and why some tumor cells eventually outcompete others.
Recovering Lives, Preventing Social Exclusion: Six Years Supporting Home Recovery and Employment Inclusion
The Recovering Lives, Preventing Social Exclusion project, promoted by Hospital Clínic Barcelona and the Training and Work Foundation (FiT), has co...
After RAS inhibitors: what comes next in pancreatic cancer?
RAS inhibitors have opened a new chapter in the treatment of pancreatic cancer, but some tumours develop resistance to these drugs. Here, we explor...
Neus Falgàs and Laura Mezquita join the Clínic-IDIBAPS 50/50 Programme
Both professionals will pursue a clinician-scientist career pathway, dividing their time equally between clinical care and research.
The Spanish Cancer Association joins the Governing Board of the Clínic Barcelona Comprehensive Cancer Centre
The Spanish Cancer Association, through its Scientific Foundation, has joined the Governing Board of the Clínic Barcelona Comprehensive Cancer Cent...
Clínic Barcelona marks 50 years since the first allogeneic bone marrow transplant
Hospital Clínic Barcelona has marked the 50th anniversary of the first allogeneic bone marrow transplant performed at the centre on June 12, 1976,...
Dr. Miquel Lozano, new President of the World Apheresis Association
Dr. Miquel Lozano Molero has been appointed President of the World Apheresis Association (WAA) for the 2026–2028 term. The election took place duri...
Clínic Barcelona Comprehensive Cancer Centre participates in ASCO 2026 with key contributions in oncology
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is participating in the American Society of Clinica...